a2 Milk recalls small U.S. batch of infant formula after toxin detected

a2 Milk Company ( (NZ:ATM) ) has provided an announcement.

The a2 Milk Company has initiated a voluntary recall of three batches of its a2 Platinum USA label infant milk formula, produced by Synlait Milk and sold only in the United States, after additional testing detected the toxin cereulide. The affected product, distributed via the company’s website, Amazon and Meijer under Operation Fly Formula and already discontinued before the recall, represents a small proportion of sales and is not expected to affect financial results.

The company said no cases of infant illness have been reported and is working with the U.S. Food and Drug Administration while advising U.S. consumers on appropriate actions. The issue is confined to the U.S. label formula, which uses a different formulation from the English-label a2 Platinum sold in other markets, and a2 Milk confirmed that all products outside the United States remain unaffected, limiting operational and reputational fallout.

The most recent analyst rating on (NZ:ATM) stock is a Sell with a N$9.20 price target. To see the full list of analyst forecasts on a2 Milk Company stock, see the NZ:ATM Stock Forecast page.

More about a2 Milk Company

The a2 Milk Company is a dairy nutrition business best known for its a2 Platinum infant milk formula and other dairy products that contain only the A2 type of beta-casein protein. The company targets premium infant formula and dairy markets globally, with English-label a2 Platinum sold in Australia, New Zealand, South Korea, Vietnam and via cross-border channels into China.

YTD Price Performance: -16.62%

Average Trading Volume: 480,937

Technical Sentiment Signal: Hold

Current Market Cap: N$6.46B

For a thorough assessment of ATM stock, go to TipRanks’ Stock Analysis page.